Lockett (leg) will undergo Regenokine treatment this week before reconvening with the Seahawks ahead of Thursday's preseason finale versus the Raiders, USA Today's Liz Mathews reports.

Lockett will need to leave the country to undergo Regenokine, as the treatment is banned by the FDA. Designed to relieve pain and expedite healing, Regenokine is performed by removing blood from a patient, then processing it before injecting it back in the body. After linebacker K.J. Wright recently underwent the process to positive results, Lockett will be joined by teammates Michael Bennett, Cliff Avril, Michael Wilhoite and Luke Joeckel in having it this week. Following completion, the players will rejoin their teammates ahead of Thursday's last exhibition contest, although it's unclear whether any of them will play. To this point, Lockett has remained sidelined following last year's broken leg, but he'll hope Regenokine enables him to be ready for Week 1.